Jump Financial, LLC Aerie Pharmaceuticals Inc Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$6.37 - $15.23 $292,039 - $698,234	45,846 New	45,846 $694,000
Q2 2022 Aug 09, 2022	SELL	$4.95 - $9.16 $107,811 - $199,504	-21,780 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$5.64 - $9.8 $122,839 - $213,444	21,780 New	21,780 $198,000
Q3 2021 Nov 12, 2021	SELL	$11.32 - $16.63 $225,924 - $331,901	-19,958 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$15.16 - $18.97 $70,372 - $88,058	4,642 Added 30.31%	19,958 $320,000
Q1 2021 May 17, 2021	BUY	$13.12 - $20.9 $200,945 - $320,104	15,316 New	15,316 $273,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.